Financials

  • Market Capitalization 2.57 B
  • Employee 124
  • Founded 2005
  • CEO N/A
  • Website www.kodiak.com
  • Headquarter Delaware, United States
  • FIGI BBG00BVR0D02
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.47
Relación precio/flujo de caja
321.87

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1822
QURE
uniQure N.V. - Ordinary Shares
41.10 USD-3.59%-1.93%+48.11%+181.51%2.59 B USD
1827
IMNM
Immunome, Inc. - Common Stock
22.80 USD-2.36%-5.00%+22.38%+166.36%2.58 B USD
1836
TARS
Tarsus Pharmaceuticals, Inc. - Common Stock
59.31 USD+2.01%-13.26%-4.46%-10.22%2.55 B USD
1845
BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
9.91 USD-5.17%-4.16%+13.13%+10.11%2.52 B USD

Noticias